TLR3 activation enhances antitumor effects of sorafenib in hepatocellular carcinoma by activating NK cell functions through ERK and NF-κB pathwaysQiangbo Zhang, Enyu Liu|Scientific Reports|2024Cited by 2
TLR3 activation enhances sorafenib-antitumor effect in hepatocellular carcinoma by activating NK cell functions through ERK and NF-κB pathwaysQiangbo Zhang, Enyu Liu|Research Square|2024Cited by 0